U.S. Food and Drug Administration (FDA) News

Johnson & Johnson to pay $586,408 settlement to Louisiana for selling defective medicines

By John Severance | Jul 6, 2017

The crux of the settlement resolves allegations that Johnson & Johnson sold medicines that did not meet federal quality requirements.

Manufacturer of chemotherapy drug targeted by Louisiana law firm in lawsuit

By Noell Wolfgram Evans | Dec 18, 2016

NEW ORLEANS — A New Orleans-based law firm is currently reviewing lawsuits of more than 30 claimants who claim they suffered permanent hair loss, also known as alopecia, allegedly caused by the chemotherapy drug Taxotere.

PPI medication lawsuits may be transferred to the Middle District of Louisiana

By S. Laney Griffo | Nov 13, 2016

BATON ROUGE — A motion for transfer has been filed with the U.S. Judicial Panel for Multidistrict Litigation (JPML) Oct. 17 regarding serious alleged kidney injuries related to the use of proton pump inhibitors.

U.S. government, agencies claim Flor Nutraceuticals sells illegal product

By The Louisiana Record | Oct 11, 2016

NEW ORLEANS — The U.S. government has filed suit against a nutraceutical company and its president for alleged misappropriation of likeness and violation of federal law after manufacturing and selling a cold sore treatment product without U.S. Food and Drug Administration (FDA) approval.

Xarelto manufacturer, distributor face more than 9,000 lawsuits

By John Breslin | Oct 10, 2016

NEW ORLEANS -- More than 9,000 lawsuits have been filed nationwide against the makers and distributors of the blood thinner Xarelto including more than 7,000 just in Louisiana.

The Record Network